Carlyle to take 20% stake in Piramal Pharma

1 July 2020 - Deborah Wilkes

Private-equity firm The Carlyle Group is taking a 20% stake in Piramal Pharma, which houses Piramal’s Consumer Products division, for around USD490 million. The investment will be used to “accelerate” Piramal Pharma’s organic and inorganic growth plans.